Comprehensive Clinical Medical Sciences Study Notes

CLINICAL ANATOMY AND MEDICAL IMAGING

Standard Anatomical Position & Body Midline

  • Standard Anatomical Position: A universal reference position used to describe anatomical structures and spatial relationships regardless of the patient's actual physical orientation.

    • Patient stands erect.

    • Head, eyes, and feet face forward.

    • Feet are flat on the floor.

    • Arms sit at the sides with palms facing forward.

  • Anatomical Midline (Median Plane): An imaginary vertical plane passing longitudinally through the center of the body, dividing it into equal right and left halves.

Anatomical Directional & Regional Terminology

Major Body Regions
  • Vertical Axis: Cephalic (head), Cervical (neck), Thoracic (chest), Abdominal (stomach).

  • Oblique Axis: Upper limbs and Lower limbs.

Directional Terms (Vertical Axis)
  • Superior (Cranial / Cephalic): Toward the head or upper part of a structure.

  • Inferior (Caudal): Toward the feet or lower part of a structure.

  • Anterior (Ventral): Toward the front of the body.

  • Posterior (Dorsal): Toward the back of the body.

  • Medial: Toward the anatomical midline.

  • Lateral: Away from the anatomical midline.

Directional Terms (Oblique Axis / Limbs)
  • Proximal: Closer to the origin of a body part or point of attachment of a limb to the trunk.

  • Distal: Farther from the origin of a body part or point of attachment of a limb to the trunk.

Region-Specific Directional Terms
  • Hand:

    • Palmar: Anterior surface of the hand.

    • Dorsal: Posterior surface of the hand.

  • Foot:

    • Plantar: Bottom surface of the foot (functionally anterior surface in directional alignment).

    • Dorsal: Top surface of the foot (functionally posterior surface in directional alignment).

    • Note: The tips of the digits (fingers and toes) represent the most distal points of the limbs.

Terms of Laterality
  • Right and Left: Always refer to the patient's right or left side, not the observer's.

  • Bilateral: Paired structures present on both sides (e.g., both kidneys).

  • Unilateral: Structure present on or affecting only one side of the body.

  • Ipsilateral: Located on or affecting the same side of the body.

  • Contralateral: Located on or affecting opposite sides of the body.

Terms of Depth
  • Superficial (External): Toward or at the body surface.

  • Deep (Internal): Away from the body surface; internal to other structures.

  • Note: Terms of depth are independent of standard anatomical position.

Terms of Body Positioning
  • Supine: Patient lying flat on their back, facing upward ("lying on the spine").

  • Prone: Patient lying flat on their stomach, facing downward.

  • Lateral Decubitus (Recumbent): Patient lying on their side.

    • Right Lateral Decubitus: Patient lying on their right side.

    • Left Lateral Decubitus: Patient lying on their left side.

Anatomical Movements

  • Flexion:

    • Extremities: Movement that decreases the angle between two body parts.

    • Spine: Forward bending.

    • Hip Flexion Range: Normally up to 140^\n\circ.

  • Extension:

    • Extremities: Movement that increases the angle between two body parts.

    • Spine: Backward bending.

    • Hip Extension Range: Normally up to 20^\n\circ.

  • Abduction: Movement away from the midline. In the hand, movement away from the 3rd digit (middle finger); in the foot, movement away from the 2nd digit.

  • Adduction: Movement toward the midline. In the hand, movement toward the 3rd digit; in the foot, movement toward the 2nd digit.

  • Medial (Internal) Rotation: Rotation toward the midline of the body.

  • Lateral (External) Rotation: Rotation away from the midline of the body.

  • Elevation: Movement of a body part in a superior direction (e.g., shrugging shoulders, closing the jaw).

  • Depression: Movement of a body part in an inferior direction (e.g., lowering shoulders, opening the jaw).

Medical Imaging Modalities, Physics, & Densities

Diagnostic Context & ALARA Principle
  • Imaging should always complement and confirm—never substitute for—a comprehensive patient history and physical examination.

  • Ionizing Radiation Risk: Radiation exposure carries potential stochastic and deterministic risks. Higher-risk populations include pediatric patients, pregnant women, young women with developing breast tissue, and patients with high cumulative lifetime doses.

  • ALARA Principle: As Low As Reasonably Achievable—minimizing radiation dose while optimizing image quality.

The 5 Radiographic Densities

Ordered from least dense (most radiolucent / darkest) to most dense (most radio-opaque / brightest):

  1. Air: Appears dark black (Radiolucent).

  2. Fat: Appears light black / dark gray.

  3. Water / Soft Tissue / Blood / Muscle: Appears medium shades of gray.

  4. Bone (Calcium): Appears white (Radio-opaque).

  5. Metal: Appears bright white (Radio-opaque).


Radiographic Densities
Comparison of Imaging Modalities

Modality

Physical Basis

Advantages

Disadvantages / Contraindications

Primary Clinical Indications

X-Ray (Plain Radiography)

Electromagnetic ionizing radiation

Readily available, inexpensive, rapid, non-invasive

Ionizing radiation; overlapping/superimposition of structures; poor soft tissue discrimination; operator-dependent

External bone injuries, fractures, joint dislocations

CT (Computed Tomography)

Rotational X-ray ionizing radiation with computer reconstruction

Excellent resolution for bones/joints; 3D rendering in axial, coronal, sagittal planes; adjustable window settings

High ionizing radiation dose; poor soft tissue detail compared to MRI; patient size/obesity limitations

Internal bone injuries, complex fractures, acute intracranial bleed, facial trauma, sinus pathology

MRI (Magnetic Resonance Imaging)

Non-ionizing strong magnetic fields & radiofrequency pulses

Superb soft tissue contrast; non-ionizing radiation; multiplanar 3D visualization

Expensive; limited availability / long wait times; lengthy scan duration; claustrophobia; Contraindicated with internal metallic implants/foreign bodies


Radiograph Reading & Orientation Rules

The "ABCs" Search Pattern for Radiographs
  • A - Anatomy & Alignment: Assess structural integrity, normal contours, and joint/bone alignment.

  • B - Bone (Smooth Cortical Integrity): Inspect for disruptions in cortical bone (fractures) and changes in bone density.

  • C - Cartilage: Evaluate joint space width and uniformity. Joint space narrowing indicates cartilage degradation or arthritis.

  • S - Soft Tissues: Examine surrounding tissue for swelling, masses, foreign objects, or abnormal gas/fluid collections.

Orientation Rules by Modality
  • Plain X-Rays:

    • AP (Anterior-to-Posterior): Beam enters anteriorly, exits posteriorly; back touches film plate. View as if standing face-to-face with the patient.

    • PA (Posterior-to-Anterior): Beam enters posteriorly, exits anteriorly; chest/front touches film plate. Read as if standing face-to-face with the patient.

    • Lateral: Named by the side of the patient touching the cassette (e.g., Left Lateral = left side against plate).

  • Cross-Sectional Imaging (CT & MRI):

    • Axial (Transverse) Plane: Horizontal slices dividing superior and inferior. View as if standing at the feet of a supine patient, looking headward from below. Patient's left is on the observer's right.

    • Coronal (Frontal) Plane: Vertical slices dividing anterior and posterior. View as if facing the patient face-to-face. Patient's left is on the observer's right.

    • Sagittal Plane: Vertical slices dividing right and left. Viewed from the side (left or right as indicated by markers).

HISTOLOGY AND TISSUE TYPES

Levels of Structural Organization & Microscopic Tools

  • Levels of Hierarchy: Atoms \n\rightarrow Molecules \n\rightarrow Organelles \n\rightarrow Cells \n\rightarrow Tissues \n\rightarrow Organs \n\rightarrow Organ Systems \n\rightarrow Organism.

  • Cell: The fundamental, functional unit of life. Life functions are sustained by the collective action of specialized cells.

  • Tissue: An aggregation of similar cells and extracellular matrix organized to perform specific functions.

  • Microscopy Modalities:

    • Light Microscope (LM): Low resolution/detail; utilized for viewing cell boundaries, tissue arrangement, and basic cellular architecture.

    • Transmission Electron Microscope (TEM): High resolution/detail; utilized for internal cellular organelles and intracellular structures.

    • Scanning Electron Microscope (SEM): High 3D resolution; utilized for surface topography and cellular surface markings.

Tissue Preparation & H&E Staining

  1. Fixation: Preserves tissue structure and prevents enzymatic autolysis or microbial decay.

  2. Embedding: Encasing tissue in a solid medium (e.g., paraffin wax) for mechanical stabilization.

  3. Sectioning: Cutting embedded tissue into ultrathin translucent slices using a microtome.

  4. Staining: Applying dyes to impart contrast to transparent cellular structures.

Hematoxylin and Eosin (H&E) Stain

The gold standard stain in diagnostic histology:

  • Hematoxylin: A basic dye that carries a positive charge. It binds to acidic (basophilic) structures and stains them blue / purple.

    • Basophilic structures: Nucleus, chromatin (DNA), nucleolus, RNA, ribosomes, cartilage extracellular matrix.

  • Eosin: An acidic dye that carries a negative charge. It binds to basic (eosinophilic / acidophilic) structures and stains them pink / red.

    • Eosinophilic structures: Cytoplasm, collagen fibers, elastic fibers, muscle filaments, mitochondria.


H&E Stained Kidney Tissue

Epithelial Tissue

Key Features
  • Covers external body surfaces, lines internal cavities/organs/blood vessels, and forms glands.

  • Composed of densely packed cells with minimal extracellular matrix and tight cell-to-cell junctions.

  • Avascular: Contains no direct blood vessels. Receives nutrients and oxygen via diffusion from underlying connective tissue blood vessels across the basement membrane.

  • Basement Membrane (BM): A thin, continuous extracellular sheet (staining dark pink) that anchors epithelium to underlying connective tissue and acts as a selective barrier.

Cell Polarity & Regions
  • Apical Region ("North Pole"): Faces the free surface, external environment, or fluid-filled interior cavity called the Lumen.

  • Basal Region ("South Pole"): Rests directly upon the basement membrane.

  • Basolateral Region ("East/West Coasts"): Surfaces where adjacent epithelial cells contact each other via cell junctions.


Simple Columnar Epithelium Diagram
Classification Rules for Epithelia
  1. Number of Layers:

    • Simple: Single layer of cells resting on the basement membrane.

    • Stratified: Two or more layers of stacked cells. (Classified by the shape of cells in the apical/top layer).

  2. Cell Shape:

    • Squamous: Flat, scale-like cells; wider than they are tall; flattened nuclei.

    • Cuboidal: Cube-shaped cells; equal height and width; central, round nuclei.

    • Columnar: Tall, cylindrical cells; height greater than width; oval nuclei positioned near the basal region.

Specific Linear Epithelial Types

Epithelial Type

Histological Description

Primary Function

Key Locations

Simple Squamous

Single layer of flat, tile-like cells

Rapid diffusion, filtration, gas exchange

Alveoli of lungs, lining of blood vessels (endothelium), cavity membranes (mesothelium)

Stratified Squamous (Non-Keratinized)

Multiple layers; apical cells are flat, alive, and retain nuclei; forms a wet membrane

Protection against abrasion and mechanical stress

Mouth, throat, esophagus, vagina

Stratified Squamous (Keratinized)

Multiple layers; apical cells are dead, lack nuclei, packed with tough keratin protein

Waterproof, hard barrier protection ("dry" membrane)

Epidermis of the skin

Simple Cuboidal

Single layer of cube-shaped cells with central round nuclei

Secretion, absorption, excretion

Kidney tubules, ducts of glands, surface of ovaries

Stratified Cuboidal

2 to 3 layers of cube-shaped cells maximum (rare)

Protection, conduit for gland secretions

Exocrine/endocrine gland ducts (e.g., sweat gland ducts)

Simple Columnar

Single layer of tall cells; oval nuclei aligned near basal line

High-capacity absorption and secretion

Gastrointestinal tract lining (stomach to rectum)

Stratified Columnar

Two layers; basal cells cuboidal, apical cells columnar (rare)

Protection, mucus secretion

Male urethra, large glandular ducts

Connective Tissue

Key Features
  • Most abundant and widely distributed tissue type by weight.

  • Functions to bind, support, protect, insulate, and transport.

  • Contains widely scattered cells surrounded by abundant Extracellular Matrix (ECM) consisting of ground substance and protein fibers.

  • Vascularity varies: from highly vascularized (areolar tissue) to poorly vascularized or avascular (cartilage).

Cellular and Fiber Components of Fibrous Connective Tissue
  • Cells:

    • Fibroblasts: Star-shaped, active mitotic cells that synthesize collagen, elastin, and ground substance.

    • Macrophages: Large phagocytic scavenger cells derived from monocytes.

  • Fibers:

    • Collagen Fibers: Thick, unbranched parallel bundles with exceptionally high tensile strength.

    • Elastin Fibers: Thin, highly branched fibers composed of elastin; provide elasticity, stretch, and recoil.

Classification of Fibrous Connective Tissue

Subdivided based on the ratio of matrix to fibers:

  • Loose Connective Tissue: High matrix volume, lower density of fibers.

    1. Loose Areolar CT: Contains scattered fibroblasts, macrophages, collagen, and elastin in a loose network. Functions as universal packing tissue filling space between organs.

    2. Adipose CT: Dominated by adipocytes storing large fat droplets that displace cytoplasm and nuclei to the periphery. Fats wash out during standard H&E processing, leaving white empty spaces. Functions in thermal conservation, shock absorption, and energy storage. Located in subcutaneous layers and surrounding organs.

  • Dense Connective Tissue: High density of fibers, minimal matrix volume.

    1. Dense Regular CT: Parallel, tightly packed collagen fibers with flattened fibroblasts squeezed between rows. Possesses extreme tensile strength along one direction. Located in tendons and ligaments.

    2. Dense Irregular CT: Interwoven, randomly arranged meshwork of thick collagen fibers. Resists multidirectional stress and stretching. Located in the dermis of the skin and organ capsules.


Fibrous Connective Tissue Subtypes

Muscle Tissue

Specialized, highly vascularized tissue composed of myocytes containing contractile proteins designed to generate physical force and movement.

  • Skeletal Muscle:

    • Histology: Long, cylindrical, unbranched fibers; striated (alternating light/dark bands of actin/myosin); multinucleated with peripherally located nuclei.

    • Control & Innervation: Voluntary control under somatic nervous system innervation.

    • Location: Attached to skeleton (e.g., biceps, quadriceps).

  • Smooth Muscle:

    • Histology: Spindle-shaped (fusiform) cells; non-striated (no visible bands); uninucleated with a centrally located nucleus.

    • Control & Innervation: Involuntary control under autonomic nervous system innervation.

    • Location: Walls of hollow visceral organs (stomach, urinary bladder, blood vessels) and exocrine ducts.


Skeletal vs Smooth Muscle Histology

PHYSIOLOGY: HOMEOSTASIS AND CELL TRANSPORT

Definition & Systemic Overview

  • Physiology: The scientific study of the mechanical, physical, and biochemical functions of living organisms and their component parts.

  • Major Organ Systems Overview:

    • Circulatory: Heart, blood vessels, blood. Transport of materials.

    • Digestive: Mouth, esophagus, stomach, intestines, liver, pancreas. Digestion, nutrient absorption, waste elimination.

    • Endocrine: Hormone-secreting glands/organs. Regulation of growth, metabolism, reproduction, blood pressure, electrolytes.

    • Immune: White blood cells, spleen, thymus. Defense against pathogens.

    • Integumentary: Skin. Protection, hydration, thermoregulation.

    • Lymphatic: Lymph vessels, lymph nodes. Extracellular fluid return, immune defense.

    • Musculoskeletal: Cartilage, bones, muscles, tendons, joints. Support, movement, hematopoiesis.

    • Nervous: Brain, spinal cord, peripheral nerves. Rapid body coordination, sensory integration, memory, cognition.

    • Reproductive: Gonads, reproductive ducts. Gamete production, fetal development.

    • Respiratory: Nose, pharynx, larynx, trachea, lungs. CO2CO_2/O2O_2 gas exchange, pH balance.

    • Urinary: Kidneys, ureters, bladder, urethra. Regulation of plasma volume, electrolyte composition, waste excretion.

Homeostasis & Control Mechanisms

  • Homeostasis: The maintenance of a stable, dynamic equilibrium within the internal physiological environment despite continuous fluctuations in external or internal conditions (e.g., maintaining pH, body temperature, blood pressure, ion concentrations).

Types of Control Mechanisms
  1. Negative Feedback: The primary mechanism of physiological homeostasis. Reverses or dampens a stimulus-induced deviation to return the variable back toward its fixed set point.

    • Examples: Body temperature regulation (shivering upon cold exposure raises temperature back to set point), blood glucose regulation (elevated plasma glucose triggers insulin release to lower blood glucose).

  2. Positive Feedback: Rare physiological mechanism. Amplifies or escalates a stimulus-induced change away from baseline, driving a process toward a decisive endpoint.

    • Examples: Labor contractions during childbirth (cervical stretch triggers oxytocin release, inducing stronger contractions), blood clotting cascades.


Negative vs Positive Feedback Loops
Components of a Homeostatic Control Loop
  1. Stimulus: A change in a regulated physiological variable.

  2. Receptor (Sensor): Detects the change in the variable.

  3. Afferent Pathway: Transmits the incoming sensory signal from the receptor to the integrating center.

  4. Integrating Center: Compares the incoming signal against a physiological set point and formulates an output response (e.g., Central Nervous System / Medulla).

  5. Efferent Pathway: Transmits outgoing command signals from the integrating center to the target organ.

  6. Effector: Muscle, gland, or organ that executes the response.

  7. Response: The action performed by the effector that modifies the initial stimulus (completing negative feedback).


Homeostatic Control Loop Components

Cell Membrane Structure & Transport Mechanics

Membrane Architecture
  • Phospholipid Bilayer: Amphipathic structure composed of:

    • Polar Head Groups: Charged, hydrophilic (water-loving); face external ECF and internal ICF environments.

    • Fatty Acyl Chains (Lipid Tails): Uncharged, nonpolar, hydrophobic (water-fearing); oriented inward away from water.

  • Membrane Proteins:

    • Integral Proteins: Embedded within the hydrophobic interior of the lipid bilayer. Transmembrane proteins span completely across the membrane with exposed intracellular and extracellular domain regions.

    • Peripheral Proteins: Polar proteins bound to the inner or outer polar surfaces of the lipid bilayer; do not penetrate the hydrophobic core.


Phospholipid Bilayer & Membrane Proteins
Types of Membrane Transport
Membrane Transport
├── Passive Transport (No ATP required; Down concentration gradient)
│   ├── Simple Diffusion (Passes directly through lipid bilayer)
│   ├── Diffusion via Channels & Pores (Pores, Ligand-gated, Mechanically-gated, Voltage-gated)
│   └── Osmosis (Water transport via Aquaporins)
└── Carrier-Mediated Transport (Utilizes specialized carrier proteins)
    ├── Facilitated Diffusion (Passive; Down gradient; No ATP)
    ├── Primary Active Transport (Requires direct ATP hydrolysis; Against gradient)
    └── Secondary Active Transport (Requires indirect energy from ion gradients; Symport/Antiport)
Passive Transport Mechanisms
  • Simple Diffusion: Direct movement of small, nonpolar, lipophilic solutes (e.g., O2O_2, CO2CO_2, steroid hormones) directly across the phospholipid bilayer down their electrochemical gradient. Requires no energy.

  • Diffusion via Pores & Channels:

    • Pores: Non-gated, continuously open transmembrane channels (e.g., K+K^+ leak channels).

    • Gated Channels: Transmembrane proteins that open or close in response to specific stimuli:

      • Ligand-Gated (Chemosensitive): Opens upon binding of a specific extracellular or intracellular chemical messenger (e.g., neurotransmitters).

      • Mechanically-Gated (Mechanosensitive): Opens in response to physical deformation or stretch of the cell membrane transmitted via the cytoskeleton.

      • Voltage-Gated: Opens in response to alterations in the electrical transmembrane potential.

  • Osmosis: Passive net diffusion of water molecules across a selectively permeable membrane via specialized water channels called Aquaporins.

Carrier-Mediated Transport Mechanisms

All carrier-mediated transport processes display specificity and saturation kinetics (maximum transport rate VmaxV_{max} when carriers are fully occupied).

  • Facilitated Diffusion: Passive transport of polar or charged solutes down their concentration gradient using a carrier protein. Requires no metabolic energy expenditure.

  • Primary Active Transport: Movement of solutes against their electrochemical gradient (low to high concentration) driven directly by the hydrolysis of ATP by integral membrane ATPases/pumps.

    • Example: Na+/K+Na^+/K^+ ATPase pump (pumps 3 Na+3\,Na^+ out of the cell and 2 K+2\,K^+ into the cell per ATP hydrolyzed).

  • Secondary Active Transport: Movement of a solute against its concentration gradient coupled to the downhill movement of a co-transported ion (typically Na+Na^+). Energy is derived indirectly from the ion gradient established by primary active transport.

    • Symport (Cotransport): Driven solute and co-transported ion move in the same direction across the membrane (e.g., Na+Na^+/glucose symporter).

    • Antiport (Countertransport): Driven solute and co-transported ion move in opposite directions across the membrane (e.g., Na+/Ca2+Na^+/Ca^{2+} exchanger, Na+/H+Na^+/H^+ exchanger).


Symport vs Antiport Mechanism

Osmosis, Osmolarity, & Tonicity

Fundamental Terminology
  • Osmolarity: Expression of total solute particle concentration per unit volume of solution.

    • Unit=mOsm/L\text{Unit} = \text{mOsm/L}

    • Normal human physiological plasma homeostasis = 290 mOsm/L290\,\text{mOsm/L} (commonly rounded to 300 mOsm/L300\,\text{mOsm/L}).

  • Osmolality: Expression of total solute particle concentration per unit mass of solvent.

    • Unit=mOsm/kg\text{Unit} = \text{mOsm/kg}

  • Colligative Property: Properties (like osmotic pressure) that depend strictly upon the total number of solute particles in a solution, independent of their chemical identity, size, or charge.

Dissociation & Osmolarity Calculations

When calculating osmolality/osmolarity, ionizing solutes dissociate into individual particles:

  • Non-dissociating molecules (1 particle1\text{ particle}): Glucose, Urea, Albumin, Starch, Sucrose.

    • 150 mmol/kg Glucose=150 mOsm/kg150\,\text{mmol/kg Glucose} = 150\,\text{mOsm/kg}

  • Monovalent salts (2 particles2\text{ particles}): NaCl→Na++Cl−NaCl \rightarrow Na^+ + Cl^-, KCl→K++Cl−KCl \rightarrow K^+ + Cl^-.

    • 150 mmol/kg NaCl=150 Na++150 Cl−=300 mOsm/kg150\,\text{mmol/kg NaCl} = 150\,\text{Na}^+ + 150\,\text{Cl}^- = 300\,\text{mOsm/kg}

  • Divalent salts (3 particles3\text{ particles}): CaCl2→Ca2++2 Cl−CaCl_2 \rightarrow Ca^{2+} + 2\,Cl^-.

    • 30 mmol/kg CaCl2=30 Ca2++60 Cl−=90 mOsm/kg30\,\text{mmol/kg CaCl}_2 = 30\,\text{Ca}^{2+} + 60\,\text{Cl}^- = 90\,\text{mOsm/kg}

Osmotic Pressure
  • Osmotic Pressure: The precise hydrostatic pressure required to completely stop the net osmotic flow of water across a selectively permeable membrane.

  • Conversion Factor: 1 mOsm/L1\,\text{mOsm/L} exerts approximately 19 mmHg19\,\text{mmHg} of osmotic pressure.

Osmotic Relationships & Tonicity Effects on Cell Volume
  • Tonicity: The effect of a solution on cell volume, determined exclusively by the concentration of non-penetrating solutes.

Solution Classification

Osmolarity vs. Cell Intracellular Fluid (300 mOsm/L300\,\text{mOsm/L})

Net Water Movement

Red Blood Cell (RBC) Volume Change

Isotonic

Equal non-penetrating solute concentration (300 mOsm/L300\,\text{mOsm/L})

No net water flux

Normal cell volume maintained

Hypertonic

Higher non-penetrating solute concentration (>300 mOsm/L>300\,\text{mOsm/L}, e.g., 400 mOsm/L400\,\text{mOsm/L})

Water flows out of the cell

Cell shrinks / crenates

Hypotonic

Lower non-penetrating solute concentration (<300 mOsm/L<300\,\text{mOsm/L}, e.g., 200 mOsm/L200\,\text{mOsm/L})

Water flows into the cell

Cell swells / lysis


Cellular Volume Changes in Solutions

CELLULAR SIGNALING AND RECEPTORS

Intercellular Communication Modes

  • Gap Junctions: Direct intercellular membrane channels that allow free passive passage of ions and small signaling molecules directly from the cytoplasm of one cell to another.

  • Autocrine Signaling: A cell secretes a chemical agent that binds to specific receptors located on its own surface.

  • Paracrine Signaling: A cell secretes a local chemical mediator that diffuses through extracellular fluid to bind receptors on nearby target cells.

  • Nervous Signaling: Neurons release neurotransmitters across a synaptic cleft to bind receptors on postsynaptic target cells.

  • Endocrine Signaling: Endocrine cells secrete hormones into the bloodstream, which transports them to distant target cells throughout the body.

  • Neuroendocrine Signaling: Specialized neurosecretory neurons release neurohormones into the bloodstream to act on distant target cells.


Endocrine Signaling Diagram

Post-Synaptic & Cell Receptors

Receptor Classes
  1. Ligand-Gated Ion Channels: Transmembrane receptors that open an intrinsic ion channel upon ligand binding, directly altering the cell's electrical potential (e.g., Nicotinic Acetylcholine Receptors facilitating Na+Na^+ influx).

  2. Enzyme-Linked Receptors: Receptors possessing intrinsic enzymatic activity (or directly coupled to enzymes) activated by ligand binding.

    • Receptor Tyrosine Kinases (RTKs): Ligand dimerization induces receptor autophosphorylation on tyrosine residues, creating docking sites for intracellular signaling proteins.

  3. G Protein-Coupled Receptors (GPCRs): 7-transmembrane domain receptors coupled to heterotrimeric G proteins consisting of α\alpha, β\beta, and γ\gamma subunits.

  4. Intracellular / Nuclear Receptors: Receptors located in the cytoplasm or nucleus that bind lipophilic ligands (e.g., steroid hormones). Ligand-receptor complexes bind to target DNA sequences to alter gene transcription.

GPCR Activation Mechanism
  1. Ligand binds to the extracellular domain of the GPCR, inducing a conformational change.

  2. The GPCR interacts with the heterotrimeric G protein complex.

  3. The GαG_\alpha subunit exchanges bound GDP for GTP.

  4. The GTP-bound GαG_\alpha subunit dissociates from the GβγG_{\beta\gamma} complex.

  5. Active Gα−GTPG_\alpha-GTP activates or inhibits specific downstream effector enzymes.

  6. Signal termination occurs when intrinsic GTPase activity of GαG_\alpha hydrolyzes GTP back to GDP, prompting reassociation of the heterotrimer.


GPCR Activation Cycle
Primary Second Messenger Cascades
GPCR Pathways
├── G_s Pathway: Stimulates Adenylyl Cyclase ──> ↑ ATP conversion to cAMP ──> Activates Protein Kinase A (PKA)
├── G_i Pathway: Inhibits Adenylyl Cyclase ──> ↓ cAMP production
└── G_q Pathway: Activates Phospholipase C (PLC)
    ├── Cleaves PIP2 into DAG and IP3
    ├── DAG ──> Activates Protein Kinase C (PKC)
    └── IP3 ──> Binds ER Receptors ──> Releases Ca2+ into Cytosol


G-protein Adenylyl Cyclase Pathway

IMMUNOLOGY: INNATE AND ADAPTIVE IMMUNITY

Hematopoiesis & Immune Cells

All cellular elements of the blood originate from Hematopoietic Stem Cells (HSCs) located in the bone marrow. HSCs divide into two primary progenitor lineages: Lymphoid Stem Cells and Myeloid Stem Cells.


Hematopoiesis Differentiation Tree
Leukocytes (White Blood Cells)
  • Polymorphonuclear Cells (PMNs / Granulocytes):

    • Neutrophils: Most abundant white blood cell (50%−70%50\% - 70\%); primary first-responder phagocytes against bacterial infections.

    • Eosinophils: (1%−3%1\% - 3\%); defense against parasitic infections, allergic reactions.

    • Basophils: (<1%<1\%); secretes histamine/heparin, involved in inflammatory and allergic responses.

  • Agranulocytes:

    • Monocytes: (2%−8%2\% - 8\%); circulate in blood, migrate into tissues to differentiate into Macrophages and Dendritic Cells (DCs).

    • Lymphocytes: (20%−40%20\% - 40\%); B cells, T cells, Natural Killer (NK) cells.

  • Non-Leukocyte Hematopoietic Elements: Erythrocytes (RBCs) and Megakaryocytes (platelet-producing cells for clotting).

Normal Adult Complete Blood Count (CBC) Reference
  • Total Normal White Blood Cell Count: 4,500 to 11,000 WBCs per microliter (4.5−11.0×109/L)4,500 \text{ to } 11,000 \text{ WBCs per microliter } (4.5 - 11.0 \times 10^9/\text{L}).

  • Clinical Correlation: Markedly elevated immature white blood cells indicates Leukemia. Abnormally high neutrophil counts combined with bacterial particles indicate Sepsis.


Leukocyte Differential Chart

Host Defense Lines

Innate Non-Immune Barriers (First Line)
  1. Physical Barriers: Intact skin (epidermis) and mucous membranes held together by tight junctions.

  2. Mechanical Barriers: Ciliary clearance in respiratory tract, blinking, sneezing, coughing, vomiting, lacrimation.

  3. Chemical Barriers: Skin fatty acids, gastric hydrochloric acid (HClHCl), lysozyme in tears and saliva, digestive enzymes.

Innate Immune Barriers (Second Line)
  • Phagocytosis: Engulfment and degradation of foreign pathogens and cell debris performed primarily by neutrophils and macrophages.

  • Inflammation: A vascular response mediated by cytokines and chemokines designed to recruit leukocytes and plasma proteins to injury/infection sites.

    • Cardinal Signs of Inflammation: Redness (rubor), Heat (calor), Swelling (tumor), Pain (dolor).

    • Mechanism: Cytokines induce local vasodilation (increasing blood flow) and cause endothelial cell contraction (increasing vascular permeability). Chemokines direct leukocyte migration (chemotaxis).


Inflammatory Response Sequence

Comparison: Innate vs. Adaptive Immunity

Feature

Innate Immunity

Adaptive Immunity

Evolutionary Presence

All multicellular organisms

Vertebrates only

Response Time

Immediate / Fast (hours)

Slow on first exposure (1−4 weeks1 - 4\text{ weeks})

Specificity

Non-specific; recognizes shared Pathogen-Associated Molecular Patterns (PAMPs)

Highly specific; recognizes unique individual epitopes

Receptors

Germline-encoded; identical on all cells of same lineage

Generated via somatic recombination; unique on each cell clone

Immunological Memory

None

Strong memory; rapid, heightened secondary response

Key Components

Physical barriers, phagocytes, PMNs, complement, cytokines

B cells, T cells, antibodies

Adaptive Immunity & Lymphocytes (Third Line)

  • Antigen: Any molecule capable of triggering an adaptive immune response (typically foreign proteins or carbohydrates).

  • Epitope: The specific antigenic determinant site recognized by an antibody or T-cell receptor.

  • Lymphocyte Antigen Receptors:

    • B Cell Receptor (BCR / Immunoglobulin / Antibody): Membrane-bound or secreted bivalent molecule.

    • T Cell Receptor (TCR): Strictly membrane-bound monovalent molecule.

    • Receptor Density: Each individual mature lymphocyte expresses approximately 100,000100,000 identical copies of its specific antigen receptor.

Functional & Structural Comparison: B Cells vs. T Cells

Feature

B Cells

T Cells

Target Antigens

Extracellular antigens (fluids, membranes)

Intracellular antigens (processed peptides)

Antigen Nature

Native protein, carbohydrate, lipid, nucleic acid

Processed linear protein peptides only

MHC Requirement

None; binds antigen directly in native state

Absolute; must be presented on MHC by Antigen-Presenting Cells (APCs)

Receptor Structure

Tetramer (2 Heavy chains + 2 Light chains); 2 binding sites

Heterodimer (1 α1\,\alpha chain + 1 β1\,\beta chain); 1 binding site

Receptor Secretion

Yes (secreted as functional Antibodies / Immunoglobulins)

No; strictly membrane-bound

Sublineages & Function

Differentiates into antibody-secreting Plasma cells and Memory B cells

CD8+CD8^+ Cytotoxic T Cells: Kill virally infected/tumor cells
CD4+CD4^+ Helper T Cells: Activate macrophages, B cells


TCR vs BCR Interaction

Primary vs. Secondary Lymphoid Organs

Primary (Central) Lymphoid Organs
  • Bone Marrow: Site of B cell origin and maturation; site of T cell origin.

  • Thymus: Site where T cell progenitor cells undergo maturation and selection.

  • Key Principle: Antigen is NOT required for the generation and maturation of naive B and T lymphocytes.

Secondary (Peripheral) Lymphoid Organs
  • Sites: Lymph nodes, Spleen, Mucosa-Associated Lymphoid Tissue (MALT - including tonsils, adenoids, appendix, Peyer's patches).

  • Function: Sites where naive lymphocytes encounter presented antigens and undergo activation, clonal expansion, and differentiation. Antigen is REQUIRED.


Organs of the Immune System Map
Microarchitecture of the Lymph Node
  • Cortex: Outer region containing B-cell rich Follicles.

    • Primary Follicles: Contain resting naive B cells.

    • Secondary Follicles / Germinal Centers: Sites of intense B cell proliferation, somatic hypermutation, and class switching following antigen activation.

  • Paracortex: T-cell rich zone located between the cortex and medulla.

  • Medulla: Deep core containing macrophages and antibody-secreting plasma cells.

  • High Endothelial Venules (HEVs): Specialized cuboidal postcapillary venules located in the paracortex that allow circulating naive lymphocytes to exit the blood and enter the lymph node.

  • Lymphatic Vessels:

    • Afferent Lymphatic Vessels (ALVs): Carry fluid, free antigens, and antigen-presenting dendritic cells INTO the lymph node from surrounding tissues.

    • Efferent Lymphatic Vessels (ELVs): Carry activated lymphocytes and lymph OUT of the lymph node toward the thoracic duct.


Lymph Node Structure

Lymphocyte Trafficking Circuit

  1. Antigen Transport: Free antigen or antigen-loaded Dendritic Cells travel from infected tissue into draining lymph nodes via Afferent Lymphatic Vessels.

  2. Naive Lymphocyte Circulation: Naive B and T cells emerge from primary organs, enter the blood pool, and pass into lymph nodes via High Endothelial Venules (HEVs).

  3. Antigen Encounter: Lymphocytes scan APCs in the lymph node zones; matched clones activate.

  4. Lymph Exit: Efferent lymphatic vessels transport lymph and lymphocytes out of the node \n\rightarrow Thoracic Duct \n\rightarrow Subclavian Vein \n\rightarrow Bloodstream.

  5. Target Migration: Activated effector lymphocytes navigate through blood to inflamed tissue guided by chemokines.


Lymphocyte Recirculation Pathway

Adaptive Immune Timeline: Primary vs. Secondary Response

Feature

Primary Adaptive Response

Secondary Adaptive Response

Responding Cells

Naive B and T cells

Expansion of specific Memory B and T cells

Lag Phase

Long (1−4 weeks1 - 4\text{ weeks}; 10−14 days10 - 14\text{ days} to peak antibody)

Extremely short (1−4 days1 - 4\text{ days} to peak antibody)

Antigen Dose Required

High

Low

Primary Antibody Isotype

IgMIgM produced prior to IgGIgG

IgGIgG predominant (IgG≫IgMIgG \gg IgM); IgAIgA/IgEIgE present

Antibody Affinity & Level

Low affinity; low serum concentration

100×100\times higher concentration; high affinity; long persistence


Primary vs Secondary Antibody Curves

Active vs. Passive Immunity

  • Active Immunity: Immunity produced by the host's own immune system following direct antigen exposure.

    • Natural Active: Recovery from natural infection.

    • Artificial Active: Vaccination (e.g., live-attenuated, inactivated, subunit, toxoid, mRNA).

    • Onset & Duration: Takes weeks to develop; long-lasting/lifelong due to memory cell generation.

  • Passive Immunity: Temporary protection acquired via transfer of preformed antibodies from an outside source.

    • Natural Passive: Maternal IgGIgG crossing placenta, maternal IgAIgA in breast milk.

    • Artificial Passive: Infusion of immune globulin / monoclonal antibodies.

    • Onset & Duration: Immediate protection; short-term duration (weeks to months) without memory cell generation.

B CELL DEVELOPMENT AND GENETICS

Immunoglobulin Molecular Structure

An antibody is a symmetrical tetrameric protein composed of two identical Heavy (H) chains and two identical Light (L) chains linked by disulfide bonds.

  • Structural Domains:

    • Fab (Fragment antigen-binding): Arm regions containing variable (VH,VLV_H, V_L) and constant (CH1,CLC_H1, C_L) domains. Contains the antigen-binding sites.

    • Fc (Fragment crystallizable): Stem region composed of heavy chain constant domains (CH2,CH3C_H2, C_H3). Interacts with cell surface Fc receptors and complement.

  • Idiotype: The unique structural sequence of the variable region (VH+VLV_H + V_L) that defines antigen specificity.

  • Isotype: The heavy chain constant region class (IgM,IgD,IgG,IgA,IgEIgM, IgD, IgG, IgA, IgE) determining effector function.


Antibody Structural Diagram

Immunoglobulin Gene Architecture

We inherit unrecombined germline immunoglobulin gene loci.

  • Heavy Chain Locus (Chromosome 14): Contains multiple Variable (VV\approx1000$), Diversity (DD\approx15$), Joining (JJ\approx5$), and Constant (CC\mu, \delta, \gamma, \epsilon, \alpha) gene segments.

  • Light Chain Loci:

    • Kappa (κ\kappa) Locus (Chromosome 2): Contains V,JV, J, and CκC_\kappa segments.

    • Lambda (λ\lambda) Locus (Chromosome 22): Contains VλV_\lambda\approx30, JλJ_\lambda, and CλC_\lambda segments.


Heavy Chain Gene Structure
Allelic Exclusion

A strict genetic mechanism ensuring each individual B cell expresses only one heavy chain allele (maternal or paternal) and only one light chain allele (maternal/paternal κ\kappa or maternal/paternal λ\lambda). This guarantees that every B cell possesses monospecific antigen binding.

Mechanisms Generating Idiotypic Diversity

  1. Somatic Recombination (Combinatorial V(D)J Joining): Enzymatic splicing and joining of random V,DV, D, and JJ gene segments mediated by RAG-1 and RAG-2 (Recombination Activating Genes).

  2. Junctional Diversity: Imprecise joining of segments where TdT (Terminal Deoxynucleotidyl Transferase) inserts random, non-templated nucleotides (N-nucleotides) into cut joints.

  3. Combinatorial Chain Pairing: Random association of independently recombined heavy chains and light chains in a single cell.

  4. Somatic Hypermutation: Post-antigen encounter point mutations in variable domains.

  • Clinical Correlation: RAG Enzyme Deficiency completely blocks somatic recombination, resulting in a total absence of mature B and T lymphocytes, causing Severe Combined Immunodeficiency (SCID).


Somatic Recombination Mechanism

Stages of B Cell Differentiation in the Bone Marrow

Bone Marrow B Cell Differentiation
Stem Cell
  └─> Pro-B Cell: Heavy Chain Recombination (RAG/TdT joins D-to-J, then V-to-DJ)
        └─> Pre-B Cell: Expresses surface µ Heavy Chain with Surrogate Light Chain (Pre-BCR)
              └─> Immature B Cell: Light Chain Recombination completed; Expresses surface IgM
                    └─> Negative Selection: Autoreactive cells undergo Apoptosis or Anergy
                          └─> Mature Naive B Cell: Co-expresses surface IgM AND IgD via Alternative RNA Splicing


B Cell Stage Lineage
Co-expression of IgM and IgD
  • Mature naive B cells leaving the bone marrow co-express both IgMIgM and IgDIgD on their cell surface.

  • This dual expression is NOT caused by DNA recombination. It is achieved via Alternative RNA Splicing of a single long primary pre-mRNA transcript containing the rearranged VDJVDJ region alongside both CμC_\mu and CδC_\delta constant regions.

  • Result: Surface IgMIgM and IgDIgD on the same mature naive B cell share the exact same idiotype (antigen binding site) but differ in their isotype.

Post-Antigen Encounter Modifications

After encountering antigen in secondary lymphoid organs, B cells undergo two DNA-altering processes mediated by the enzyme AID (Activation-Induced Cytidine Deaminase):

  1. Somatic Hypermutation: High-frequency point mutations introduced into the variable regions (VHV_H and VLV_L). Selection selects B cells with higher affinity for antigen (Affinity Maturation).

  2. Isotype (Class) Switching: Recombination replacing the CμC_\mu constant region with CγC_\gamma, CαC_\alpha, or CϵC_\epsilon. Changes antibody class from IgMIgM to IgGIgG, IgAIgA, or IgEIgE without altering the variable region or antigen idiotype specificity.

Fate of Activated B Cells
  • Short-Lived Plasma Cells: Secretes early IgMIgM antibodies.

  • Long-Lived Plasma Cells: Reside in bone marrow; secrete high-affinity switched antibodies (IgG,IgA,IgEIgG, IgA, IgE).

  • Memory B Cells: Long-lived cells ready for rapid secondary response.


B Cell Differentiation Fate
Comprehensive Summary of B Cell Genetic Events

Event

Location

Antigen Dependency

Genetic Mechanism

Region Affected

Somatic Recombination

Bone Marrow

Antigen-INDEPENDENT

DNA Rearrangement (RAG/TdT)

Variable regions (VH,D,JH,VL,JLV_H, D, J_H, V_L, J_L)

IgM & IgD Co-expression

Bone Marrow

Antigen-INDEPENDENT

Alternative RNA Splicing

Constant region (CμC_\mu and CδC_\delta)

Somatic Hypermutation

Secondary Lymphoid Organs

Antigen-DEPENDENT

Point Mutation (AID)

Variable regions (VH,VLV_H, V_L)

Isotype Switching

Secondary Lymphoid Organs

Antigen-DEPENDENT

DNA Deletion/Recombination (AID)

Constant region (CHC_H)

BIOCHEMISTRY: DNA STRUCTURE AND REPLICATION

Nucleic Acid Composition & Central Dogma

  • Central Dogma: Information flows unidirectionally from DNA \n\rightarrow RNA \n\rightarrow Protein.

    1. Transcription: DNA template transcribed into mRNA.

    2. Translation: mRNA translated into functional protein.

    3. Reverse Transcription: Retroviruses (e.g., HIV) synthesize DNA from an RNA template via reverse transcriptase.


Central Dogma Diagram

Nucleotide Chemistry

Components of Nucleotides
  1. Nitrogenous Base:

    • Purines (2 rings): Adenine (A), Guanine (G), Hypoxanthine ("AG is TOO pure" = 2 rings).

    • Pyrimidines (1 ring): Cytosine (C), Thymine (T) (DNA only), Uracil (U) (RNA only) ("King T-U-C lived in the Pyramid" = 1 ring).

  2. Pentose Sugar:

    • Ribose (RNA): Contains an −OH-OH hydroxyl group at the 2′2' carbon.

    • 2'-Deoxyribose (DNA): Lacks oxygen at the 2′2' carbon (contains −H-H).

  3. Phosphate Group(s): 1, 2, or 3 phosphate groups bound at the 5′5' carbon.


Purines vs Pyrimidines
Chemical Nomenclature
  • Nucleoside = Nitrogenous Base + Sugar (1′1' Glycosidic bond).

    • Purine Nucleosides: End in "-osine" (Adenosine, Guanosine, Inosine).

    • Pyrimidine Nucleosides: End in "-idine" (Cytidine, Thymidine, Uridine).

  • Nucleotide = Nucleoside + Phosphate group(s).

    • Examples: AMP, dAMP, ADP, dATP, dCDP.

Chemical Bonds Within & Between Nucleotides
  • Glycosidic Bond: Covalent bond joining the 1′1' carbon of pentose sugar to the nitrogenous base.

  • Phosphoester Bond: Bond connecting the α\alpha-phosphate group to the 5′5' carbon hydroxyl of the sugar.

  • Phosphoanhydride Bonds: High-energy bonds joining α−β\alpha-\beta and β−γ\beta-\gamma phosphate groups.

  • Phosphodiester Bond: High-energy linkage joining the 3′3' hydroxyl group of one nucleotide sugar to the 5′5' phosphate group of an adjacent nucleotide. During synthesis, substrate (d)NTPs are cleaved releasing pyrophosphate (PPiPP_i), providing energy to form the phosphodiester bond.


Phosphodiester Bond Formation

Watson-Crick Double Helix Model

  • B-Form DNA: Right-handed double helix with 10 base pairs per 360^\n\circ complete turn (pitch of 3.4 nm3.4\,\text{nm}).

  • Hydrophilic Backbone: Deoxyribose-phosphate backbone sits on the exterior.

  • Hydrophobic Core: Nitrogenous bases stack on the interior stabilized by van der Waals forces.

  • Antiparallel Strands: One strand runs 5′→3′5' \rightarrow 3', complementary strand runs 3′→5′3' \rightarrow 5'.

  • Complementary Base Pairing:

    • Adenine = Thymine: Paired via 2 Hydrogen bonds (weaker bond; melts easily).

    • Guanine ≡\equiv Cytosine: Paired via 3 Hydrogen bonds (stronger, highly stable).

  • Major and Minor Grooves: Alternating deep (major) and shallow (minor) grooves along the helix.

    • Clinical Correlation: Dactinomycin (Actinomycin D) intercalates specifically into the minor groove of GC-rich DNA regions, creating a physical roadblock that inhibits both DNA replication and transcription. Used as a cancer chemotherapeutic.


DNA Double Helix Structure

Cell Cycle Regulation & DNA Replication

Cell Cycle Phases
  • G1G_1 (Gap 1): Cell growth, protein synthesis, accumulation of replication building blocks (6−12 hr6 - 12\,\text{hr}).

  • SS (Synthesis): Chromosomal DNA replication (6−8 hr6 - 8\,\text{hr}).

  • G2G_2 (Gap 2): Final preparations for mitosis, ATP accumulation (3−4 hr3 - 4\,\text{hr}).

  • MM (Mitosis): Nuclear and cytoplasmic division (1 hr1\,\text{hr}).

  • G0G_0 (Senescence): Quiescent phase for non-dividing, terminally differentiated cells.


Cell Cycle Diagram
Molecular Regulation: Cyclins, CDKs, and Retinoblastoma (Rb)
  • Cyclin-Dependent Kinases (CDKs 1, 2, 4, 6): Kinases expressed continuously that require binding of specific cyclins to become active.

  • Cyclins (A, B, D, E): Regulatory proteins whose concentrations fluctuate predictably across cell cycle phases.

    • Cyclin D + CDK4 / CDK6: Promotes progression through G1G_1 phase.

    • Cyclin E + CDK2: Drives G1→SG_1 \rightarrow S phase transition.

  • Retinoblastoma Protein (Rb): Tumor suppressor protein ("the brake"). In its unphosphorylated state, Rb binds and sequesters the E2F transcription factor.

  • Physiological Inactivation of Rb:

    1. Sequential phosphorylation of Rb by Cyclin D/CDK4, Cyclin D/CDK6, and Cyclin E/CDK2 hyperphosphorylates Rb.

    2. Hyperphosphorylated Rb releases E2F.

    3. Free E2F transcribes genes required for S phase entry (e.g., DNA polymerases, MCM, SSB).


Rb Protein Inactivation Mechanism

Process of Eukaryotic DNA Replication

Key Replication Enzymes & Factors
DNA Replication Complex
├── Origins of Replication (ori): Multiple AT-rich regions in eukaryotes
├── Unwinding Machinery
│   ├── ORC, Cdc6, Cdt1: Recruits helicase to origin
│   ├── MCM Complex (Helicase): Unwinds double helix by breaking H-bonds
│   ├── Single-Stranded Binding Proteins (SSB): Prevents reannealing of single strands
│   └── Topoisomerases (I & II): Relieves torsional strain and supercoils
└── Polymerization Machinery
    ├── Primase (Pol α subunit): Synthesizes short RNA primers de novo
    ├── Pol α: Initiates daughter strand elongation
    ├── Pol ε: Continuous leading strand synthesis
    ├── Pol δ: Discontinuous lagging strand synthesis (Okazaki fragments)
    └── DNA Ligase: Seals phosphodiester backbone nicks
  • Topoisomerase Inhibitors:

    • Quinolones (Ciprofloxacin, Levofloxacin): Inhibit bacterial Type II topoisomerase (DNA gyrase).

    • Etoposide: Inhibits eukaryotic Type II topoisomerase; used in cancer chemotherapy.

Synthesis Dynamics at the Replication Fork
  • Directionality: DNA polymerases read template strands 3′→5′3' \rightarrow 5' and synthesize new complementary strands exclusively 5′→3′5' \rightarrow 3'.

  • Priming: Polymerases cannot synthesize DNA de novo. Primase (subunit of Pol α\alpha) must synthesize an RNA primer with a free 3′−OH3'-OH group.

  • Leading Strand: Synthesized continuously toward the advancing replication fork by DNA Polymerase ϵ\epsilon.

  • Lagging Strand: Synthesized discontinuously away from the replication fork by DNA Polymerase δ\delta in short segments called Okazaki fragments.


Replication Fork Dynamics
Eukaryotic DNA Polymerases Overview

Polymerase

Primary Function

3′→5′3' \rightarrow 5' Exonuclease Proofreading

Pol α\alpha

Contains primase; initiates DNA synthesis

No (-)

Pol β\beta

DNA repair

No (-)

Pol γ\gamma

Replicates mitochondrial DNA

Yes (+)

Pol δ\delta

Elongates Okazaki fragments on lagging strand

Yes (+)

Pol ϵ\epsilon

Elongates leading strand

Yes (+)

Proofreading & Chain Termination
  • Proofreading: Pol δ,ϵ,γ\delta, \epsilon, \gamma possess 3′→5′3' \rightarrow 5' exonuclease activity that excises mismatched base pairs, maintaining replication fidelity.

  • Chain-Terminating Nucleoside Analogs: Drugs lacking a 3′−OH3'-OH group (e.g., Zidovudine/AZT, Lamivudine). Viral polymerases lack proofreading exonuclease activity and cannot excise incorporated chain terminators, halting viral replication.

  • Geminin: Protein that binds newly synthesized origin DNA during S/G2 phases to prevent re-replication within a single cell cycle.

BIOCHEMISTRY: RNA STRUCTURE AND TRANSCRIPTION

RNA Classes & Functional Roles

RNA Type

Structure & Features

Primary Function

rRNA (Ribosomal)

Comprises 60%60\% of ribosome mass; enzymatic ribozyme activity

Structural and catalytic core of ribosomes

mRNA (Messenger)

Single-stranded working copy of genetic code; capped and polyadenylated

Carries genetic codons from nucleus to cytoplasm for translation

tRNA (Transfer)

Cloverleaf 2D2D / L-shaped 3D3D fold; contains unusual bases, CCA 3′3' acceptor arm, anticodon loop

Adapts amino acids to corresponding mRNA codons during translation

snRNA (Small Nuclear)

Complexed with proteins into snRNPs ("snurps": U1, U2, etc.)

Catalyzes pre-mRNA splicing and intron removal in nucleus

snoRNA (Small Nucleolar)

Non-coding guide RNA

Directs chemical modifications (methylation) of rRNA/tRNA

miRNA (MicroRNA)

Small single-stranded regulatory RNA

Base-pairs with target mRNA causing cleavage or translation suppression


tRNA Cloverleaf Structure

Antibiotics Targeting Ribosomal Subunits

Ribosomal Inhibitor Antibiotics
├── 50S Large Subunit Targets
│   ├── Macrolides (Azithromycin, Erythromycin)
│   ├── Clindamycin
│   ├── Linezolid
│   ├── Chloramphenicol
│   └── Streptogramins
└── 30S Small Subunit Targets
    ├── Tetracyclines (Doxycycline)
    └── Aminoglycosides (Gentamicin)


Antibiotics Targeting Bacterial Ribosomes

Eukaryotic RNA Polymerases

  • RNA Polymerase I: Transcribes major rRNA (28S,18S,5.8S28S, 18S, 5.8S).

  • RNA Polymerase II: Transcribes mRNA, snRNA, miRNA.

  • RNA Polymerase III: Transcribes tRNA, 5S5S rRNA.

  • Mnemonics: Pol I = RRNA (1st letter); Pol II = MRNA (2nd letter sounds like m); Pol III = TRNA (Three starts with T).

Eukaryotic Transcription Regulation & Requirements

Basal Requirements
  1. Promoter: Essential upstream DNA sequence (−10 to −35 bp-10 \text{ to } -35\,\text{bp}) marking gene start. Includes the TATA Box (5′−TATAAA−3′5'-TATAAA-3') or GC Box.

  2. General (Basal) Transcription Factors:

    • TFIID: Contains TBP (TATA-Binding Protein); recognizes and binds the TATA box.

    • TFIIF: Finds and escorts RNA Polymerase II to the promoter.

    • TFIIH: Helicase that unwinds DNA and phosphorylates RNA Pol II to initiate transcription.

  3. RNA Polymerase II: Reads template DNA 3′→5′3' \rightarrow 5'; synthesizes mRNA 5′→3′5' \rightarrow 3' de novo without a primer.


Transcription Pre-initiation Complex
Chromatin Remodeling & Enhancers/Silencers
  • Euchromatin: Open, transcriptionally active DNA.

  • Heterochromatin: Condensed, transcriptionally silent DNA.

  • Histone Acetyltransferases (HATs): Acetylate lysine residues on histones, relaxing chromatin to turn transcription ON.

  • Histone Deacetylases (HDACs): Remove acetyl groups, condensing chromatin to turn transcription OFF.

  • Enhancers & Activators: Specific transcription factor activators bind distant enhancer DNA sequences, recruiting HAT coactivators to turn transcription ON.

    • Glucocorticoid Receptor Example: Cortisol binds GR \n\rightarrow GR dimerizes \n\rightarrow Enters nucleus \n\rightarrow Binds GRE (Glucocorticoid Response Element) enhancer \n\rightarrow Recruits HATs \n\rightarrow Initiates transcription of anti-inflammatory genes.

  • Silencers & Repressors: Repressor proteins bind silencer DNA sequences, recruiting HDACs to condense chromatin OFF.


Glucocorticoid Receptor Activation Mechanism

Prokaryotic Transcription & Polymerase Inhibitors

  • Prokaryotic RNA Polymerase: Single enzyme complex.

    • Core Enzyme: 2α,1β,1β′,1Ω2\alpha, 1\beta, 1\beta', 1\Omega subunits.

    • Holoenzyme: Core Enzyme + Sigma (σ\sigma) Factor (binds promoter).

  • RNA Polymerase Inhibitors:

    • Rifampin: Binds β\beta subunit of bacterial RNA polymerase, blocking transcription initiation. Used against Tuberculosis.

    • Alpha-Amanitin: Toxin from Amanita phalloides (death cap mushroom). Inactivates eukaryotic RNA Polymerase II, causing severe liver failure.

Post-Transcriptional Processing of Pre-mRNA

Primary transcripts (hnRNA / pre-mRNA) produced in the nucleus undergo three maturation steps before cytoplasm export:

  1. 5′5' Capping: Addition of 7-methylguanosine in an unusual 5′→5′5' \rightarrow 5' triphosphate linkage. Protects mRNA from degradation and enhances translation.

  2. 3′3' Polyadenylation: Cleavage downstream of polyadenylation signal (5′−AAUAAA−3′5'-AAUAAA-3') followed by addition of a Poly-A tail (40−20040 - 200 A residues) by Polyadenylate Polymerase.

  3. Splicing: Removal of non-coding Introns and ligation of coding Exons executed by the Spliceosome.

    • Splice Sites: 5′5' Splice Donor site and 3′3' Splice Acceptor site.

    • Alternative Splicing: Assembles different exon combinations from a single pre-mRNA, generating over 100,000100,000 distinct proteins from ≈30,000\approx30,000 human genes.


Splicing of Introns and Exons
Splice Site Mutation Rules
  • Moving 5′5' splice donor upstream into exon \n\rightarrow Shortens Exon 1.

  • Moving 5′5' splice donor downstream into intron \n\rightarrow Lengthens Exon 1.

  • Moving 3′3' splice acceptor upstream into intron \n\rightarrow Lengthens Exon 2.

  • Moving 3′3' splice acceptor downstream into exon \n\rightarrow Shortens Exon 2.

QUESTIONS & DISCUSSION

  • Q: What is the orientation relative to my right shoulder and left knee?

    • Answer: Superior and contralateral.

  • Q: How is an exercise displaying shoulder abduction and elbow flexion categorized?

    • Answer: Abduction of shoulder, flexion of elbow.

  • Q: How should axial/transverse CT or MRI images be interpreted?

    • Answer: As if you are standing at the feet of a supine patient, looking toward their head.

  • Q: In H&E staining, what cellular structures stain purple/blue?

    • Answer: Nuclei and chromatin (basophilic structures containing nucleic acids).

  • Q: What transport mechanism moves K+ out through leak channels without ATP?

    • Answer: Simple diffusion / Pore-mediated passive transport down its concentration gradient.

  • Q: If an RBC (300 mOsm/kg300\text{ mOsm/kg}) is placed in 145 mmol/kg145\text{ mmol/kg} NaCl, what happens to its volume?

    • Answer: 145 mmol/kg NaCl=290 mOsm/kg145\text{ mmol/kg NaCl} = 290\text{ mOsm/kg} (isosmotic/isotonic). RBC volume remains unchanged.

  • Q: Which solution is hypertonic to 1 mOsm/kg1\text{ mOsm/kg} NaCl (2 mOsm/kg2\text{ mOsm/kg} total)?

    • Answer: 1 mmol/kg CaCl21\text{ mmol/kg } CaCl_2 (3 mOsm/kg3\text{ mOsm/kg} total) or 1 mmol/kg KCl1\text{ mmol/kg } KCl (2 mOsm/kg2\text{ mOsm/kg} active osmotic force).

  • Q: What is the primary advantage of giving passive immunization?

    • Answer: Faster, immediate protection upon administration.

  • Q: Lack of which enzyme causes SCID?

    • Answer: RAG (Recombination Activating Gene) deficiency.

  • Q: What sequence is synthesized by primase for template 5'-A-A-G-C-G-G-T-T-A-3'?

    • Answer: Complementary RNA strand in 5′→3′5' \rightarrow 3' orientation is 5'-U-A-A-C-C-G-C-U-U-3'.

  • Q: If the DNA template strand is 5'-TTGCGCAC-3', what is the transcribed RNA sequence?

    • Answer: Flip template to 3′→5′3' \rightarrow 5' (3'-CACGCGTT-5'); complementary RNA is 5'-GUGCGCAA-3'.

  • Q: Which subunit of prokaryotic RNA polymerase is inhibited by Rifampin?

    • Answer: Beta (β\beta) subunit.

  • Q: If a splice site mutation moves the 3'-splice site 21 nucleotides downstream into Exon 2, what is the outcome?

    • Answer: Exon 2 will be 21 nucleotides shorter.